For Immediate Release
Contact: Marc Cannon
Billboard Chart-Topping Artist Joe Nichols to Perform at the Inaugural AutoNation Cure Bowl Tailgate Party and Concert
FORT LAUDERDALE, Fla., November 11, 2015 – AutoNation, Inc. (NYSE: AN), America’s largest automotive retailer, announced that the critically acclaimed, award-winning, singer-songwriter, Joe Nichols, will be the headline artist at the inaugural AutoNation Cure Bowl Tailgate Party and Concert.
On December 19th, AutoNation will sponsor the first AutoNation Cure Bowl at the Orlando Citrus Bowl to benefit the Breast Cancer Research Foundation, The largest private funder of breast cancer research in the world. BCRF is also the highest rated breast cancer organization in the U.S. with an A+ rating from Charity Watch and the top four-star rating from Charity Navigator.
“I’m honored to join AutoNation in the fight against cancer.” said Joe Nichols, “So many lives have been affected by this terrible disease, mine included, and I want to do my part to raise awareness and funds for breast cancer research. I believe that together we can tackle this.”
Award-winning country artist Jana Kramer will also be performing at the tailgate concert. “The only thing better than performing with someone as talented as Joe Nichols is knowing that we are both there for such an amazing and worthwhile cause,” said Kramer.
Each ticket to the AutoNation Cure Bowl game admits entry into the AutoNation Cure Bowl Tailgate Party and Concert. Tickets can be purchased by visiting CureBowl.com. The game day events will start at 3pm. Gates into the stadium open at 5:30 pm and kick-off is at 7:00p.m.
In 2013, AutoNation shifted its charitable focus to aiding in finding a cure for cancer by increasing the attention placed on awareness and preventative measures. Since then, AutoNation has raised $5 million for cancer related charities and has committed $1,000,000 to the Breast Cancer Research Foundation to invest in the world’s most promising research.
About the Breast Cancer Research Foundation The Breast Cancer Research Foundation (BCRF) is committed to being the end of breast cancer by advancing the world’s most promising research. Founded by Evelyn H. Lauder in 1993, BCRF-funded investigators have been deeply involved in every major breakthrough in breast cancer prevention, diagnosis, treatment and survivorship. In 2015, BCRF awarded $48.5 million to support 240 researchers at leading medical institutions internationally, making it one of the largest non-governmental funders of breast cancer research in the world. By investing 91 cents of every dollar directly in its mission,